Cytomegaloviral Retinitis
📧 Sign up to get email alerts when something new happens for Cytomegaloviral Retinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-06-22FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for VALCYTE (valganciclovir) submitted by H2-Pharma, LLC.